Safety, Reactogenicity and Immunogenicity of a Novel MVA-SARS-2-ST Vaccine Candidate

NCT05226390 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
23
Enrollment
OTHER
Sponsor class

Stopped cohort could not be recruited

Conditions

Interventions

Sponsor

Hannover Medical School

Collaborators